Injection‐site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization

1. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916–918. 2. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004–1013. 3. Brinkmann F, Schwerk N, Hansen G, Ballmann M. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis. Allergy 2010;65:134–135. 4. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008;43:1249–1251. 5. Van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62:276–277. 6. Pérez-de-Llano LA, Vennera MC, Parra A, Guallar J, Marin M, Asensio O et al. Effects of omalizumab in Aspergillus-associated airway disease. Thorax 2011;11:epub. Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization